Register
Login:
Share:
Email Facebook Twitter


Michael Masterman talks on WRES potential & Tungsten market


Premaitha Share Price (NIPT)



Share Price Information for Premaitha (NIPT)


Share Price: 10.75Bid: 10.50Ask: 11.00Change: 0.00 (0.00%)No Movement on Premaitha
Spread: 0.50Spread as %: 4.76%Open: 10.75High: 10.75Low: 10.75Yesterday’s Close: 10.75

Premaitha Health Plc Ord 0.1P

Premaitha is listed in the FTSE AIM All-Share
Premaitha is part of the Medicine and Biotech Research sector






Share Price SpacerPrice
10.75

Share Price SpacerBid
10.50

Share Price SpacerAsk
11.00

Share Price SpacerChange
0%0.00

Share Price SpacerVolume
5,573

Share Price SpacerOpen
10.75

Share Price SpacerHigh
10.75

Share Price SpacerLow
10.75

Share Price SpacerClose
10.75

Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 321.22m £34.53m 20,000

52 Week High 13.88 52 Week High Date 6-MAR-2017
52 Week Low 7.38 52 Week Low Date 3-FEB-2017

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
2 5,573 0 -1.792 -6.00 0.00 0.00




Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

30-Mar-17
10:35:36
10.65
2,440
Sell* 
10.50
11.00
259.86
Trade Type:
Ordinary

30-Mar-17
10:01:15
10.655
3,133
Sell* 
10.50
11.00
333.82
Trade Type:
Ordinary

29-Mar-17
15:50:17
10.50
42,300
Sell* 
10.50
11.00
4,442
Trade Type:
Ordinary




View more Premaitha trades >>

Directors Deals for Premaitha (NIPT)
Trade DateActionNotifierPriceCurrencyAmountHolding
17-Dec-15Buy
Trade Notifier Information for Premaitha Health
Barry Kenneth Hextall held the position of CFO at Premaitha Health at the time of this trade.
 Barry Kenneth Hextall
18.03GBX180,736332498
02-Nov-15Notification of Holding
Trade Notifier Information for Premaitha Health
William Denman held the position of Chief Medical Officer at Premaitha Health at the time of this trade.
 William Denman
00250000
02-Jul-15Placing
Trade Notifier Information for Premaitha Health
Barry Kenneth Hextall held the position of CFO at Premaitha Health at the time of this trade.
 Barry Kenneth Hextall
20GBX150,000151762
View more Premaitha directors dealings >>



Date/TimeAuthorSubjectShare PriceOpinion
Today 09:39notaflipperRE: Innogene liquid biopsy oncology10.75No Opinion
The thing that interested me in this story is that INNOGEN are the Parent Company of Centrum Badan. This is the Czech lab partner of Premaitha and whom are currently being sued by Illumina. It was very interesting to me that despite this Innogene still allowed one of its other sub-companies (whose names and website details are shared in the post) to have Illumina as their NGS technology partner in their workflow. I am sure some are asking given the relationship with Innogene could Premaitha… Read More
Today 09:04HemoRE: Innogene liquid biopsy oncology10.75No Opinion
For laymen like me can you explain what this means for Premaitha? I understand what liquid biopsy is but who are innogene and where does this leave us? Is this a threat to us or does it underline the opportunity?

Thanks

Hemo
Today 07:34twix386wouldn't surprise me10.75No Opinion
if we miss the window of opportunity as writ and delays with commercialisation of IONA and head-winds have seen us focus on NIPT to the exclusion and delay in targetting liquid biopsy or finding a funding partner. I have seen various articles of progress being made elsewhere which will see us later to the game than would have been hoped and may diminish our advantages. aimho
Today 07:06jackdaw99RE: Innogene liquid biopsy oncology10.75No Opinion
Shows what's possible given the platform we already have....
Wed 23:05notaflipperInnogene liquid biopsy oncology10.75No Opinion
COMMISSION FOR FINANCIAL SUPERVISION
Current Report No. 3/2017
Date of preparation: 2017-03-27
Short name of the issuer
INNO GENE S.A.
Topic
Launch of liquid biopsy tests by a subsidiary
Legal basis
Art. 1 MAR - confidential information.
Report content:
The Board of INNO-GENE S.A. _Emitent_ took on 27 March this year. Information that a subsidiary of the Issuer Research Center DNA sp.z. Headquartered in Poznan, Poland has successfully completed validation and has begun tests for the… Read More
Tue 07:59Hugh-JarseCourt case..?11.00No Opinion
Feel free to pick holes or correct.......

As far as I'm aware the court case is still set for Mon 03Jul 2017.
Likely to last 12 days followed by 2 days of summing up.

I've had this link from some time back and keep checking now & then.
Just wondering if I was up with events thus far. Anyone got anything better?

https://www.justice.gov.uk/courts/court-lists/list-patents-court-diary/section-1.pdf

*Scroll down, we are on page 8.

Share prices shown are taken at time of message posting.
Thread ViewThread View
View more share chat for Premaitha (NIPT) >>

Please login or register to post a message on Share Chat.








Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk








Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.